Professional Media briefs: April 2013

Share this article:
Linda Snetselaar
Linda Snetselaar

Wiley is providing immunity and inflammatory disease professionals with a new open-access journal: Immunity, Inflammation and Disease. The interdisciplinary publication launched March 4. All published content will be covered by a Creative Commons license. The company also launched the Journal of Medical Radiation Sciences February 22. This open-access title merged The Radiographer and Shadows.

University of Iowa professor of epidemiology Linda Snetselaar is taking over as editor-in-chief of the Journal of the Academy of Nutrition and Dietetics, as noted by Gorkana. She will be the publication's sixth editor-in-chief in its 88 years of publication and replaces Linda Van Horn who has been EIC since 2003. Snetselaar starts June 1.

The American Psychiatric Nurses Association has endorsed and helped shape an eLearning course, Handling Psychiatric Emergencies. The new course, published by Elsevier, includes live-action video, ethical issue considerations, links to drug monographs and continuing education credits, among other features. The course was written by the Emergency Nurses Association and launched February 28.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?